Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Qiu, Hai Bo ^a   Zhang, Li Yi ^b   Keshari, Rajiv Prasad ^a   Wang, Guo Qiang ^a   Zhou, Zhi Wei ^a   Xu, Da Zhi ^a   Wang, Wei ^a   Zhan, You Qin ^a   Li, Wei ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; PROTEIN P53; VIRUS DNA;

ADULT; AGED; ARTICLE; BACTERIUM DETECTION; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OVERALL SURVIVAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH SURGERY; TUMOR LOCALIZATION; FOLLOW UP; GENETICS; MICROBIOLOGY; MIDDLE AGED; MUCOSA; PATHOLOGY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; STOMACH TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

ADULT; AGED; CARCINOMA, SIGNET RING CELL; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 77954545365     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-374     Document Type: Article

References (43)

1. Garcia JAM, Ward EM, Center MM, Hao Y, Siegel RL, Thun MJ. Global Cancer Facts & Figures 2007. 2007, Atlanta, GA: American Cancer Society.
2. Xu DZ, Geng QR, Long ZJ, Zhan YQ, Li W, Zhou ZW, Chen YB, Sun XW, Chen G, Liu Q. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol 2009, 16(2):319-326. 10.1245/s10434-008-0240-4, 19050970.
3. Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 2005, 241(2):247-255. 10.1097/01.sla.0000152019.14741.97, 1356909, 15650634.
4. Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 2003, 21(19):3647-3650. 10.1200/JCO.2003.01.240, 14512396.
5. NCCN NCCN clinical practice guideline: gastric cancer. vol. version 1 2009, 2009. NCCN.
6. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984, 1(8390):1311-1315. 10.1016/S0140-6736(84)91816-6, 6145023.
7. IARC Monographs on the evaluation of carcinogenic risk to humans. 1994, 61. Lyon: World Health Organization.
8. Group HaCC Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001, 49(3):347-353. 10.1136/gut.49.3.347, 1728434, 11511555, Group HaCC.
9. Tajima K. Challenging epidemiological strategy for paradoxical evidence on the risk of gastric cancer from Helicobacter pylori infection. Jpn J Clin Oncol 2002, 32(8):275-276. 10.1093/jjco/hyf078, 12411563.
10. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997, 40(3):297-301. 1027076, 9135515.
11. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998, 115(3):642-648. 10.1016/S0016-5085(98)70143-X, 9721161.
12. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998, 58(19):4255-4259.
13. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. J Natl Cancer Inst 2000, 92(23):1881-1888. 10.1093/jnci/92.23.1881, 11106679.
14. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001, 345(11):784-789. 10.1056/NEJMoa001999, 11556297.
15. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 2008, 105(3):1003-1008. 10.1073/pnas.0711183105, 2242726, 18192401.
16. Yang Y, Deng CS, Peng JZ, Wong BC, Lam SK, Xia HH. Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cells. Mol Pathol 2003, 56(1):19-24. 10.1136/mp.56.1.19, 1187283, 12560457.
17. Calcagno DQ, Leal MF, Assumpcao PP, Smith MA, Burbano RR. MYC and gastric adenocarcinoma carcinogenesis. World J Gastroenterol 2008, 14(39):5962-5968. 10.3748/wjg.14.5962, 2760197, 18932273.
18. Kazunari Murakami MK, Toshio F. Latest insights into the effects of Helicobacter pylori infection on gastric carcinogenesis. World J Gastroenterol 2006, 12(17):2713-2720.
19. Wu MS, Hung HW, Wang JT, Tseng CC, Shun CT, Wang HP, Lee WJ, Lin JT. Helicobacter pylori-seronegative gastric carcinoma: a subset of gastric carcinoma with distinct clinicopathologic features. Hepatogastroenterology 1998, 45(24):2432-2436.
20. Rocco A, Caruso R, Toracchio S, Rigoli L, Verginelli F, Catalano T, Neri M, Curia MC, Ottini L, Agnese V, et al. Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. Ann Oncol 2006, 17(Suppl 7):vii103-108. 10.1093/annonc/mdl961, 16760271.
21. Meimarakis G, Winter H, Assmann I, Kopp R, Lehn N, Kist M, Stolte M, Jauch KW, Hatz RA. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol 2006, 7(3):211-222. 10.1016/S1470-2045(06)70586-1, 16510330.
22. Marrelli D, Pedrazzani C, Berardi A, Corso G, Neri A, Garosi L, Vindigni C, Santucci A, Figura N, Roviello F. Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer 2009,
23. Lehours FMgaP Helicobacter pylori Detection and Antimicrobial Susceptibility Testing. Clinical Microbiology Reviews 2007, 20:280-322. 10.1128/CMR.00033-06, 17428887, Lehours FMgaP.
24. Sobin LHWC, . (ed) TNM Classification of Malignant Tumors. 2002, 6, (ed).
25. Marrelli D, Pinto E, De Stefano A, Farnetani M, Garosi L, Roviello F. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg 2001, 181(1):16-19. 10.1016/S0002-9610(00)00549-3, 11248169.
26. Megraud F. H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004, 53(9):1374-1384. 10.1136/gut.2003.022111, 1774187, 15306603.
27. Liu H, Rahman A, Semino-Mora C, Doi SQ, Dubois A. Specific and sensitive detection of H. pylori in biological specimens by real-time RT-PCR and in situ hybridization. PLoS One 2008, 3(7):e2689. 10.1371/journal.pone.0002689, 2481290, 18648543.
28. Lawson AJ, Elviss NC, Owen RJ. Real-time PCR detection and frequency of 16S rDNA mutations associated with resistance and reduced susceptibility to tetracycline in Helicobacter pylori from England and Wales. J Antimicrob Chemother 2005, 56(2):282-286. 10.1093/jac/dki199, 15958499.
29. Ernst P. Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther 1999, 13(Suppl 1):13-18. 10.1046/j.1365-2036.1999.00003.x, 10209682.
30. Elnemr A, Yonemura Y, Bandou E, Kinoshita K, Kawamura T, Takahashi S, Tochiori S, Endou Y, Sasaki T. Expression of collagenase-3 (matrix metalloproteinase-13) in human gastric cancer. Gastric Cancer 2003, 6(1):30-38. 10.1007/s101200300004, 12673424.
31. Kabashima A, Maehara Y, Kakeji Y, Baba H, Koga T, Sugimachi K. Clinicopathological features and overexpression of matrix metalloproteinases in intramucosal gastric carcinoma with lymph node metastasis. Clin Cancer Res 2000, 6(9):3581-3584.
32. Monig SP, Baldus SE, Hennecken JK, Spiecker DB, Grass G, Schneider PM, Thiele J, Dienes HP, Holscher AH. Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma. Histopathology 2001, 39(6):597-602. 10.1046/j.1365-2559.2001.01306.x, 11903578.
33. Gooz M, Gooz P, Smolka AJ. Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells. Am J Physiol Gastrointest Liver Physiol 2001, 281(3):G823-832.
34. Xue LJ, Su QS, Yang JH, Lin Y. Autoimmune responses induced by Helicobacter pylori improve the prognosis of gastric carcinoma. Med Hypotheses 2008, 70(2):273-276. 10.1016/j.mehy.2007.05.045, 17681432.
35. Lee WJ, Lin JT, Lee WC, Shun CT, Hong RL, Cheng AL, Lee PH, Wei TC, Chen KM. Clinicopathologic characteristics of Helicobacter pyloric seropositive gastric adenocarcinomas. J Clin Gastroenterol 1995, 21(3):203-207. 10.1097/00004836-199510000-00007, 8648053.
36. Lee WJ, Lin JT, Shun CT, Lee WC, Yu SC, Lee PH, Chang KJ, Wei TC, Chen KM. Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori. Br J Surg 1995, 82(6):802-805. 10.1002/bjs.1800820627, 7627516.
37. Hobsley M, Tovey FI, Holton J. Helicobacter pylori and gastric cancer: neither friend nor foe. Gastroenterology 2007, 132(5):2076. 10.1053/j.gastro.2007.03.088, 17484909.
38. Rad R, Prinz C, Schmid RM. Helicobacter pylori and prognosis of gastric carcinoma. Lancet Oncol 2006, 7(5):364-365. 10.1016/S1470-2045(06)70672-6, 16648041.
39. Monteiro L, de Mascarel A, Sarrasqueta AM, Bergey B, Barberis C, Talby P, Roux D, Shouler L, Goldfain D, Lamouliatte H, et al. Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests. Am J Gastroenterol 2001, 96(2):353-358. 10.1111/j.1572-0241.2001.03518.x, 11232675.
40. Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007, 20(2):280-322. 10.1128/CMR.00033-06, 1865594, 17428887.
41. Mattsson A, Lonroth H, Quiding-Jarbrink M, Svennerholm AM. Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination. J Clin Invest 1998, 102(1):51-56. 10.1172/JCI22, 509064, 9649556.
42. Bamford KB, Fan X, Crowe SE, Leary JF, Gourley WK, Luthra GK, Brooks EG, Graham DY, Reyes VE, Ernst PB. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998, 114(3):482-492. 10.1016/S0016-5085(98)70531-1, 9496938.
43. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997, 6(8):639-642.